Earlier Diagnosis the Myocardial Infarction of Older Patients by Troponin Test

Background: Finding elevations or decreases in cardiac troponin (cTn) is crucial for the early diagnosis of myocardial infarction (MI). Myocardial necrosis is indicated by cardiac troponins. They are the favored due to their strong cardiac selectivity. Biomarker to detect instances of MI. Techniques: Seventy older people between the ages of 55 and 75 were involved in a prospective comparison study that took place between January 2021 and December 2023. They were split up into two groups: the first group consisted of 70 patients, while the second group contained 50 healthy people as a control group. Results: Sensitive troponin I testing significantly improved the diagnosis of myocardial infarction in women (from 12% to 23%; P < 0.001) but had little effect on males (from 21% to 23%; P = 0.002). P < 0.05 was less likely in women than in men for both coronary artery revascularization and cardiologist referral. Women with unexplained increases in troponin concentration (16–48 ng/L) and those with myocardial infarction (≥55 ng/L) had higher rates of death or re-infarction at 24 months (26%, 28%, and 6%, respectively; P < 0.001), as compared to women without myocardial infarction (≤18 ng/L). Conclusion: elevated sensitivity a sex-specific diagnostic beginning for the troponin assay might binary the identification of myocardial infarction in women and recognize those who are most vulnerable to reinfarction and demise. Whether applying sex-specific analytic thresholds will enhance results and address issues, even though they don't really affect males disparities in how women are treated who may have care for acute coronary syndrome must be given immediately.